Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression

ConditionHIV Viremia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Texas, El Paso

About this trial

The study will test two behavioral intervention components to identify the combination of the two components that best supports people who inject drugs to achieve and sustain HIV viral load suppression.

The study design is a 2-to-the-2 factorial experiment. The 2 represents the level of each component: 0 (receive) or 1 (don't receive). The 2 represents the number of components being tested. The four components are: 1) receiving (or not receiving) peer support services for medication-assisted treatment (MAT) uptake and persistence and 2) behavioral activation therapy for depression (BAT). Therefore, in order to test which combination of components produce the best outcome, this factorial design randomizes people to 1 of 4 conditions. Each condition represents a possible combination of the 2 components above. All participants will receive patient navigation for care engagement.

Eligibility criteria

Qualifiers

be at least 18 years of age

be able to provide informed consent

be eligible to receive free HIV care services in Mexico

be HIV positive

Disqualifiers

has not injected drugs in the last 30 days or do not have a verifiable opioid use disorder

is not HIV positive

is receiving methadone

is unwilling to discuss methadone uptake with a peer

Trial design

Treatments tested in this trial

  • Peer support to promote uptake and persistence of medication assisted treatment (MAT)
  • Behavioral Activation Treatment (BAT) to reduce depression
  • No Intervention Components

Treatment groups

220 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Texas, El Paso

Lead sponsor

University of California, San Francisco

Collaborator

Centro de Integracion Juvenil

Collaborator

El Centro Ambulatorio para la Prevención y Atención en SIDA e Infecciones de Transmisión Sexual

Collaborator